Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide plus interferon beta versus placebo plus interferon beta in relapsing multiple sclerosis
2010-023172-12Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Teriflunomide + interferon beta with Placebo + interferon beta (2 arms). Primary endpoint: Annualized relapse rate. Started Nov 2010; status: terminated.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2010-023172-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023172-12.